BRPI0822997A2 - Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use - Google Patents

Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use

Info

Publication number
BRPI0822997A2
BRPI0822997A2 BRPI0822997-0A BRPI0822997A BRPI0822997A2 BR PI0822997 A2 BRPI0822997 A2 BR PI0822997A2 BR PI0822997 A BRPI0822997 A BR PI0822997A BR PI0822997 A2 BRPI0822997 A2 BR PI0822997A2
Authority
BR
Brazil
Prior art keywords
immunomodulatory
extracts
manufacture
methods
lactobacillus bacteria
Prior art date
Application number
BRPI0822997-0A
Other languages
Portuguese (pt)
Inventor
Jacques Alain Bauer
Marco Salvagni
Jean-Pierre Leon Vigroux
Laetitia Leela Gisele Chalvet
Carlo Chiavaroli
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of BRPI0822997A2 publication Critical patent/BRPI0822997A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
BRPI0822997-0A 2008-09-04 2008-09-04 Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use BRPI0822997A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/010350 WO2010027344A1 (en) 2008-09-04 2008-09-04 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

Publications (1)

Publication Number Publication Date
BRPI0822997A2 true BRPI0822997A2 (en) 2015-06-23

Family

ID=41797341

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822997-0A BRPI0822997A2 (en) 2008-09-04 2008-09-04 Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use

Country Status (11)

Country Link
JP (1) JP2012502026A (en)
KR (1) KR20110051268A (en)
CN (1) CN102143756A (en)
AU (1) AU2008361375B2 (en)
BR (1) BRPI0822997A2 (en)
CA (1) CA2733249A1 (en)
IL (1) IL211041A0 (en)
MX (1) MX2011002080A (en)
RU (1) RU2500412C2 (en)
WO (1) WO2010027344A1 (en)
ZA (1) ZA201100899B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2670415A4 (en) 2011-02-02 2014-11-26 Justbio Inc Functional foods and beverages with synergistic properties to promote homeostasis
WO2012130968A1 (en) * 2011-03-29 2012-10-04 Nestec S.A. Natural derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with a further improved immune profile
US9309492B2 (en) * 2011-03-29 2016-04-12 Nestec S.A. Derivative of the Lactobacilus johnsonii strain CNCM I-1225, deficient in D-lactic acid production and with an improved shelf life
US20130022586A1 (en) 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
AU2013209887B2 (en) 2012-01-16 2021-02-18 Elizabeth Mckenna Compositions and methods for the treatment of hepatic diseases and disorders
US20140086849A1 (en) 2012-09-21 2014-03-27 Elizabeth McKenna Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof
US20150017208A1 (en) * 2013-07-12 2015-01-15 National Yang-Ming University Lactic acid bacterium having immunomodulatory and anti-allergic effects
JP6821643B2 (en) * 2013-09-26 2021-01-27 雪印メグミルク株式会社 Immune disease preventive agent
JP6491422B2 (en) * 2013-09-26 2019-03-27 雪印メグミルク株式会社 Immune disease preventive
CN103798392B (en) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 There is the probiotic food composition and food of alleviating bottleneck throat inflammation effect
KR101627806B1 (en) * 2014-06-23 2016-06-07 한국식품연구원 The culturing method for increasing immune-enhancing activity in Lactobacillus spp.
JP6940305B2 (en) 2017-06-01 2021-09-22 株式会社明治 How to make cheese flavored ingredients
KR102335710B1 (en) 2017-10-31 2021-12-07 (주)아모레퍼시픽 Immunomodulatory composition comprising extracellular vesicles derived from lactic acid bacteria
TWI731209B (en) * 2018-01-09 2021-06-21 柯順議 Probiotics composition and uses thereof
CN112534043B (en) 2018-05-09 2024-04-26 Ko生物技术有限公司 Lactobacillus paracasei strain and application thereof
WO2019235592A1 (en) * 2018-06-07 2019-12-12 国立大学法人金沢大学 Pharmaceutical composition for prevention or treatment of kidney damage
US20210220309A1 (en) * 2018-06-07 2021-07-22 National University Corporation Kanazawa University Pharmaceutical composition for prevention or treatment of kidney damage
CN109007842A (en) * 2018-10-29 2018-12-18 广州普维君健药业有限公司 Have effects that prevent and treat the probiotic composition of allergy and its application
KR102156829B1 (en) * 2019-02-22 2020-09-18 가톨릭대학교 산학협력단 Composition for preventing or treating immune diseases comprising mixture of Microbiome
CN109628359B (en) * 2019-02-22 2021-03-02 江南大学 Lactobacillus reuteri capable of relieving allergic asthma and application thereof
CA3132564A1 (en) 2019-03-14 2020-09-17 Om Pharma Sa Process for making stable bacterial extracts and their use as pharmaceuticals
CN110643541B (en) * 2019-10-25 2021-08-24 江南大学 Lactobacillus casei capable of adjusting Th2/Th1 balance of allergic asthma and application thereof
CN111053789A (en) * 2019-11-26 2020-04-24 湖南营养树生物科技有限公司 Methods and compositions for modulating the immune system
EP4084784A4 (en) * 2020-01-13 2024-01-17 Univ Monash Compositions and methods
CN111548961A (en) * 2020-05-15 2020-08-18 郑州和合生物工程技术有限公司 Probiotic composition for improving allergic diseases, probiotic composition powder, preparation method and application
CN111991428A (en) * 2020-06-12 2020-11-27 郑州和合生物工程技术有限公司 Probiotic composition with asthma improving effect and preparation method thereof
CN112057479B (en) * 2020-11-16 2021-02-12 河北一然生物科技有限公司 Probiotic composition capable of relieving diarrhea caused by antibiotics
KR102424594B1 (en) * 2020-11-30 2022-07-25 파이토지노믹스 주식회사 Lactobacillus fermentum OKBL-L.FE 1 strain having anti-inflammatory activity and antimicrobial activity against pathogenic microorganism and uses thereof
KR20230001127A (en) 2021-06-28 2023-01-04 농업회사법인 산청바이오진생마을 주식회사 Method for manufacturing ginseng sprout
KR20230131450A (en) * 2022-03-03 2023-09-13 한국생명공학연구원 Composition for treating inflammatory disease comprising N-carbamyl-L-glutamic acid
CN114774302B (en) * 2022-03-09 2023-06-16 善恩康生物科技（苏州）有限公司 Application of lactobacillus plantarum CQPC02 in preparation of product for preventing and/or treating lupus nephritis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH532903A (en) * 1971-06-25 1973-01-31 Nestle Sa Process of extracting proteins from cells of microorganisms
JP3004890B2 (en) * 1995-03-28 2000-01-31 雪印乳業株式会社 Pathogen infection protective agent
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
RU2302458C2 (en) * 2001-07-26 2007-07-10 Элиментери Хелс Лимитед Lactobacillus salivarius probiotic strain (variants), probiotic preparation based on the same, and method for treatment or prevention using lactobacillus salivarius strains
PE20030274A1 (en) * 2001-07-26 2003-05-08 Alimentary Health Ltd LACTOBACILLUS SALIVARIUS STRAINS
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
ES2531597T3 (en) * 2004-03-04 2015-03-17 E-L Management Corp. Skin treatment procedure with Lactobacillus extract
BRPI0611493B1 (en) * 2005-05-31 2022-04-05 Alimentary Health Ltd. Feline probiotic lactobacilli
JP2007269737A (en) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd Interleukin production regulator, pharmaceutical composition and food and drink comprising the interleukin production regulator and method for producing the same
JP5019961B2 (en) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 Interleukin 10 production promoter

Also Published As

Publication number Publication date
JP2012502026A (en) 2012-01-26
ZA201100899B (en) 2012-05-30
AU2008361375B2 (en) 2014-05-22
CA2733249A1 (en) 2010-03-11
WO2010027344A1 (en) 2010-03-11
AU2008361375A1 (en) 2010-03-11
RU2500412C2 (en) 2013-12-10
MX2011002080A (en) 2011-03-29
CN102143756A (en) 2011-08-03
RU2011112781A (en) 2012-10-10
KR20110051268A (en) 2011-05-17
IL211041A0 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
BRPI0822997A2 (en) Immunomodulatory extracts of lactobacillus bacteria and methods for their manufacture and use
BRPI1011384A2 (en) proproteins and their methods of use
BRPI1014544A2 (en) anti-il-17f anticorpors and methods of use
BRPI0916269A2 (en) tissue modification device and its method of use
HRP20160859T1 (en) Modified rsv f proteins and methods of their use
BRPI1011404A2 (en) mutants and their uses
BRPI0909077A2 (en) Multilayer articles and methods of preparation and use
BR112013013167A2 (en) bromodomain inhibitors and their uses
BRPI0922708A2 (en) minihepidine peptides and methods of use thereof
BRPI1007175A2 (en) Mutant hydroxyphenylpriruvate dioxigenase polypeptides and methods of use
BRPI1009847A2 (en) Medical connectors and methods of use
BRPI1010024A2 (en) aminopyrrolidinone derivatives and their use
BR112012004375A2 (en) beach towel and beach towel method
BRPI0918693A2 (en) sampling devices and methods for the concentration of microorganisms
BRPI1013432A2 (en) indolizine derivative and use thereof for medical purposes
BRPI0924440A2 (en) bone restoration apparatus and methods of use
BRPI1005960A2 (en) implant system and use of an implant system
BRPI0913086A2 (en) Antimicrobial Compositions and Methods of Use
BR112013014751A2 (en) sterilization blanket system and methods of use
BRPI0909954A2 (en) "diazacarbazoles and methods of use"
BRPI0907575A2 (en) Binding visual properties of charts and cells within tables
BR112013014321A2 (en) innovative modulators and methods of use
BR112014009837A2 (en) Effective use of yeast and yeast extract
BRPI0816835A2 (en) spraying device and method of use
BRPI0922344A2 (en) tfpi inhibitors and methods of use

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.